HSR21-073: Febrile Neutropenia Outcomes Among Patients With Breast Cancer and Non-Hodgkin’s Lymphoma Receiving Pegfilgrastim Prophylaxis: A Real-World Analysis of Commercial and Medicare Claims From 2017-2018

Authors: Weijia Wang MSc, Edward Li PharmD, MPH 1 , Kim Campbell PharmD, BCOP 1 and Ali McBride PharmD, MS, BCOP, FAzPA, FASHP 2 , 3
View More View Less
  • 1 Sandoz Inc., Princeton, NJ
  • 2 Banner University Medical Center, Tucson, AZ
  • 3 University of Arizona Cancer Center, Tucson, AZ
Volume/Issue:
Volume 19: Issue 3.5
Online Publication Date:
17 Mar 2021
DOI:
https://doi.org/10.6004/jnccn.2020.7718
Restricted access

All currencies in US Dollar

PayPal Logo

Corresponding Author: Weijia Wang, MSc
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Page Numbers:
HSR21-073
Article Category:
Abstract
Print Publication Date:
20 Mar 2021
Online Publication Date:
17 Mar 2021
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 97 97 59
PDF Downloads 160 160 63
EPUB Downloads 0 0 0